A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.
Category: Health Insurance and Managed Care
-
The Medicine Is a Miracle, but Only if You Can Afford It
The New York Times – Business: -
New Medicare Rule Aims to Take Back $4.7 Billion From Insurers
The New York Times – Business:The government plans to aggressively audit Medicare Advantage plans for overbilling but may face lawsuits.
-
Emailing Your Doctor May Carry a Fee
The New York Times – Business:More hospitals and medical practices have begun charging for doctors’ responses to patient queries, depending on the level of medical advice.
-
California Sues Companies Over Insulin Prices, Joining Other States
The New York Times – Business:The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
-
Medicare Begins to Rein In Drug Costs for Older Americans
The New York Times – Business:Reforms embedded in the Inflation Reduction Act will bring savings to seniors this year. Already some lawmakers are aiming to repeal the changes.
-
U.S. Health Officials Seek New Curbs on Private Medicare Advantage Plans
The New York Times – Business:Proposed regulations would crack down on misleading ads for the private plans and would enhance scrutiny of denials for coverage of medical care.
-
A Guide to Signing Up for Health Coverage
The New York Times – Business:With the deadline near for marketplace medical insurance, a video offers some down-to-earth advice for navigating numerous options and obscure terms.
-
From the DealBook Summit: Leaders Look Into the Future
The New York Times – Business:Groundbreakers at the conference were asked what’s coming next for the brain, climate, medicine, labor, security and business.
-
What if You Could Go to the Hospital … at Home?
The New York Times – Business:Hospital-at-home care is an increasingly common option, and it is often a safer one for older adults. But the future of the approach depends on federal action.
